<?xml version='1.0' encoding='utf-8'?>
<document id="29644537"><sentence text="Drug-Drug Interaction Profile of the Fixed-Dose Combination Tablet Regimen Ledipasvir/Sofosbuvir."><entity charOffset="75-85" id="DDI-PubMed.29644537.s1.e0" text="Ledipasvir" /><entity charOffset="86-96" id="DDI-PubMed.29644537.s1.e1" text="Sofosbuvir" /><pair ddi="false" e1="DDI-PubMed.29644537.s1.e0" e2="DDI-PubMed.29644537.s1.e0" /><pair ddi="false" e1="DDI-PubMed.29644537.s1.e0" e2="DDI-PubMed.29644537.s1.e1" /></sentence><sentence text="Ledipasvir/sofosbuvir (HarvoniÂ®), a fixed-dose combination tablet of an NS5A inhibitor ledipasvir and an NS5B polymerase inhibitor sofosbuvir, is approved for the treatment of chronic hepatitis C virus infection"><entity charOffset="0-10" id="DDI-PubMed.29644537.s2.e0" text="Ledipasvir" /><entity charOffset="11-21" id="DDI-PubMed.29644537.s2.e1" text="sofosbuvir" /><entity charOffset="87-97" id="DDI-PubMed.29644537.s2.e2" text="ledipasvir" /><entity charOffset="131-141" id="DDI-PubMed.29644537.s2.e3" text="sofosbuvir" /><pair ddi="false" e1="DDI-PubMed.29644537.s2.e0" e2="DDI-PubMed.29644537.s2.e0" /><pair ddi="false" e1="DDI-PubMed.29644537.s2.e0" e2="DDI-PubMed.29644537.s2.e1" /><pair ddi="false" e1="DDI-PubMed.29644537.s2.e0" e2="DDI-PubMed.29644537.s2.e2" /><pair ddi="false" e1="DDI-PubMed.29644537.s2.e0" e2="DDI-PubMed.29644537.s2.e3" /><pair ddi="false" e1="DDI-PubMed.29644537.s2.e1" e2="DDI-PubMed.29644537.s2.e1" /><pair ddi="false" e1="DDI-PubMed.29644537.s2.e1" e2="DDI-PubMed.29644537.s2.e2" /><pair ddi="false" e1="DDI-PubMed.29644537.s2.e1" e2="DDI-PubMed.29644537.s2.e3" /><pair ddi="false" e1="DDI-PubMed.29644537.s2.e2" e2="DDI-PubMed.29644537.s2.e2" /><pair ddi="false" e1="DDI-PubMed.29644537.s2.e2" e2="DDI-PubMed.29644537.s2.e3" /></sentence><sentence text=" Ledipasvir/sofosbuvir exhibits a favorable drug-drug interaction profile and can be administered with various medications that may be used by hepatitis C virus-infected patients, including patients with comorbidities, such as co-infection with human immunodeficiency virus or immunosuppression following liver transplantation"><entity charOffset="1-11" id="DDI-PubMed.29644537.s3.e0" text="Ledipasvir" /><entity charOffset="12-22" id="DDI-PubMed.29644537.s3.e1" text="sofosbuvir" /><pair ddi="false" e1="DDI-PubMed.29644537.s3.e0" e2="DDI-PubMed.29644537.s3.e0" /><pair ddi="false" e1="DDI-PubMed.29644537.s3.e0" e2="DDI-PubMed.29644537.s3.e1" /></sentence><sentence text=" Ledipasvir/sofosbuvir is not expected to act as a victim or perpetrator of cytochrome P450- or UDP-glucuronosyltransferase 1A1-mediated drug-drug interactions"><entity charOffset="1-11" id="DDI-PubMed.29644537.s4.e0" text="Ledipasvir" /><entity charOffset="12-22" id="DDI-PubMed.29644537.s4.e1" text="sofosbuvir" /><pair ddi="false" e1="DDI-PubMed.29644537.s4.e0" e2="DDI-PubMed.29644537.s4.e0" /><pair ddi="false" e1="DDI-PubMed.29644537.s4.e0" e2="DDI-PubMed.29644537.s4.e1" /></sentence><sentence text=" With the exception of strong inducers of P-glycoprotein, such as rifampin, ledipasvir/sofosbuvir is not expected to act as a victim of clinically relevant drug-drug interactions"><entity charOffset="66-74" id="DDI-PubMed.29644537.s5.e0" text="rifampin" /><entity charOffset="76-86" id="DDI-PubMed.29644537.s5.e1" text="ledipasvir" /><entity charOffset="87-97" id="DDI-PubMed.29644537.s5.e2" text="sofosbuvir" /><pair ddi="false" e1="DDI-PubMed.29644537.s5.e0" e2="DDI-PubMed.29644537.s5.e0" /><pair ddi="false" e1="DDI-PubMed.29644537.s5.e0" e2="DDI-PubMed.29644537.s5.e1" /><pair ddi="false" e1="DDI-PubMed.29644537.s5.e0" e2="DDI-PubMed.29644537.s5.e2" /><pair ddi="false" e1="DDI-PubMed.29644537.s5.e1" e2="DDI-PubMed.29644537.s5.e1" /><pair ddi="false" e1="DDI-PubMed.29644537.s5.e1" e2="DDI-PubMed.29644537.s5.e2" /></sentence><sentence text=" As a perpetrator of pharmacokinetic drug-drug interactions via P-glycoprotein/BCRP, ledipasvir/sofosbuvir should not be used with rosuvastatin and elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate, whereas its co-administration with amiodarone is not recommended because of a pharmacodynamic interaction"><entity charOffset="85-95" id="DDI-PubMed.29644537.s6.e0" text="ledipasvir" /><entity charOffset="96-106" id="DDI-PubMed.29644537.s6.e1" text="sofosbuvir" /><entity charOffset="131-143" id="DDI-PubMed.29644537.s6.e2" text="rosuvastatin" /><entity charOffset="148-160" id="DDI-PubMed.29644537.s6.e3" text="elvitegravir" /><entity charOffset="161-171" id="DDI-PubMed.29644537.s6.e4" text="cobicistat" /><entity charOffset="172-185" id="DDI-PubMed.29644537.s6.e5" text="emtricitabine" /><entity charOffset="186-215" id="DDI-PubMed.29644537.s6.e6" text="tenofovir disoproxil fumarate" /><entity charOffset="252-262" id="DDI-PubMed.29644537.s6.e7" text="amiodarone" /><pair ddi="false" e1="DDI-PubMed.29644537.s6.e0" e2="DDI-PubMed.29644537.s6.e0" /><pair ddi="false" e1="DDI-PubMed.29644537.s6.e0" e2="DDI-PubMed.29644537.s6.e1" /><pair ddi="false" e1="DDI-PubMed.29644537.s6.e0" e2="DDI-PubMed.29644537.s6.e2" /><pair ddi="false" e1="DDI-PubMed.29644537.s6.e0" e2="DDI-PubMed.29644537.s6.e3" /><pair ddi="false" e1="DDI-PubMed.29644537.s6.e0" e2="DDI-PubMed.29644537.s6.e4" /><pair ddi="false" e1="DDI-PubMed.29644537.s6.e0" e2="DDI-PubMed.29644537.s6.e5" /><pair ddi="false" e1="DDI-PubMed.29644537.s6.e0" e2="DDI-PubMed.29644537.s6.e6" /><pair ddi="false" e1="DDI-PubMed.29644537.s6.e0" e2="DDI-PubMed.29644537.s6.e7" /><pair ddi="false" e1="DDI-PubMed.29644537.s6.e1" e2="DDI-PubMed.29644537.s6.e1" /><pair ddi="false" e1="DDI-PubMed.29644537.s6.e1" e2="DDI-PubMed.29644537.s6.e2" /><pair ddi="false" e1="DDI-PubMed.29644537.s6.e1" e2="DDI-PubMed.29644537.s6.e3" /><pair ddi="false" e1="DDI-PubMed.29644537.s6.e1" e2="DDI-PubMed.29644537.s6.e4" /><pair ddi="false" e1="DDI-PubMed.29644537.s6.e1" e2="DDI-PubMed.29644537.s6.e5" /><pair ddi="false" e1="DDI-PubMed.29644537.s6.e1" e2="DDI-PubMed.29644537.s6.e6" /><pair ddi="false" e1="DDI-PubMed.29644537.s6.e1" e2="DDI-PubMed.29644537.s6.e7" /><pair ddi="false" e1="DDI-PubMed.29644537.s6.e2" e2="DDI-PubMed.29644537.s6.e2" /><pair ddi="false" e1="DDI-PubMed.29644537.s6.e2" e2="DDI-PubMed.29644537.s6.e3" /><pair ddi="false" e1="DDI-PubMed.29644537.s6.e2" e2="DDI-PubMed.29644537.s6.e4" /><pair ddi="false" e1="DDI-PubMed.29644537.s6.e2" e2="DDI-PubMed.29644537.s6.e5" /><pair ddi="false" e1="DDI-PubMed.29644537.s6.e2" e2="DDI-PubMed.29644537.s6.e6" /><pair ddi="false" e1="DDI-PubMed.29644537.s6.e2" e2="DDI-PubMed.29644537.s6.e7" /><pair ddi="false" e1="DDI-PubMed.29644537.s6.e3" e2="DDI-PubMed.29644537.s6.e3" /><pair ddi="false" e1="DDI-PubMed.29644537.s6.e3" e2="DDI-PubMed.29644537.s6.e4" /><pair ddi="false" e1="DDI-PubMed.29644537.s6.e3" e2="DDI-PubMed.29644537.s6.e5" /><pair ddi="false" e1="DDI-PubMed.29644537.s6.e3" e2="DDI-PubMed.29644537.s6.e6" /><pair ddi="false" e1="DDI-PubMed.29644537.s6.e3" e2="DDI-PubMed.29644537.s6.e7" /><pair ddi="false" e1="DDI-PubMed.29644537.s6.e4" e2="DDI-PubMed.29644537.s6.e4" /><pair ddi="false" e1="DDI-PubMed.29644537.s6.e4" e2="DDI-PubMed.29644537.s6.e5" /><pair ddi="false" e1="DDI-PubMed.29644537.s6.e4" e2="DDI-PubMed.29644537.s6.e6" /><pair ddi="false" e1="DDI-PubMed.29644537.s6.e4" e2="DDI-PubMed.29644537.s6.e7" /><pair ddi="false" e1="DDI-PubMed.29644537.s6.e5" e2="DDI-PubMed.29644537.s6.e5" /><pair ddi="false" e1="DDI-PubMed.29644537.s6.e5" e2="DDI-PubMed.29644537.s6.e6" /><pair ddi="false" e1="DDI-PubMed.29644537.s6.e5" e2="DDI-PubMed.29644537.s6.e7" /><pair ddi="false" e1="DDI-PubMed.29644537.s6.e6" e2="DDI-PubMed.29644537.s6.e6" /><pair ddi="false" e1="DDI-PubMed.29644537.s6.e6" e2="DDI-PubMed.29644537.s6.e7" /></sentence><sentence text=" This review summarizes a number of drug interaction studies conducted in support of the clinical development of ledipasvir/sofosbuvir"><entity charOffset="113-123" id="DDI-PubMed.29644537.s7.e0" text="ledipasvir" /><entity charOffset="124-134" id="DDI-PubMed.29644537.s7.e1" text="sofosbuvir" /><pair ddi="false" e1="DDI-PubMed.29644537.s7.e0" e2="DDI-PubMed.29644537.s7.e0" /><pair ddi="false" e1="DDI-PubMed.29644537.s7.e0" e2="DDI-PubMed.29644537.s7.e1" /></sentence><sentence text="" /></document>